Literature DB >> 3172149

Osteoporosis-pseudoglioma syndrome: clinical, morphological, and biochemical studies.

H Somer1, A Palotie, M Somer, V Hoikka, L Peltonen.   

Abstract

We report a sibship of a sister and brother with osteoporosis-pseudoglioma syndrome. Several other family members became blind or showed signs of bone involvement. There was considerable consanguinity in the pedigree. The proband was small in size and had prominent skeletal deformities and clinical muscle weakness. These features were not present in her brother, suggesting clinical variability. Mental function was normal in both. Bone histology showed osteopenia. Several biochemical events of procollagen biosynthesis were analysed in fibroblast cultures, but no significant abnormalities compared to control fibroblast cultures were detected.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3172149      PMCID: PMC1080031          DOI: 10.1136/jmg.25.8.543

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  10 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Posttranslational enzymes in the biosynthesis of collagen: intracellular enzymes.

Authors:  K I Kivirikko; R Myllylä
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

3.  The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2(I) chains which are not incorporated into trimers of type I procollagen.

Authors:  S B Deak; A Nicholls; F M Pope; D J Prockop
Journal:  J Biol Chem       Date:  1983-12-25       Impact factor: 5.157

4.  The ocular form of osteogenesis imperfecta: a new autosomal recessive syndrome.

Authors:  P Beighton; I Winship; D Behari
Journal:  Clin Genet       Date:  1985-07       Impact factor: 4.438

5.  Modified procedure for the assay of H-3-or C-14-labeled hydroxyproline.

Authors:  K Juva; D J Prockop
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

6.  Collagen biosynthesis in systemic scleroderma: regulation of posttranslational modifications and synthesis of procollagen in cultured fibroblasts.

Authors:  L Peltonen; A Palotie; R Myllylä; T Krieg; A Oikarinen
Journal:  J Invest Dermatol       Date:  1985-01       Impact factor: 8.551

7.  Autosomal recessive syndrome of pseudogliomantous blindness, osteoporosis and mild mental retardation.

Authors:  G Neuhäuser; E G Kaveggia; J M Opitz
Journal:  Clin Genet       Date:  1976-03       Impact factor: 4.438

8.  Histomorphometric normal values of the iliac crest cancellous bone in a Finnish autopsy series.

Authors:  V Hoikka; I Arnala
Journal:  Ann Clin Res       Date:  1981-12

9.  Osteogenesis imperfecta is linked to both type I collagen structural genes.

Authors:  B Sykes; D Ogilvie; P Wordsworth; N Jones
Journal:  Lancet       Date:  1986-07-12       Impact factor: 79.321

10.  Osteoporosis-pseudoglioma syndrome: report of three affected sibs and an overview.

Authors:  M Frontali; C Stomeo; B Dallapiccola
Journal:  Am J Med Genet       Date:  1985-09
  10 in total
  10 in total

1.  Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13.

Authors:  Y Gong; M Vikkula; L Boon; J Liu; P Beighton; R Ramesar; L Peltonen; H Somer; T Hirose; B Dallapiccola; A De Paepe; W Swoboda; B Zabel; A Superti-Furga; B Steinmann; H G Brunner; A Jans; R G Boles; W Adkins; M J van den Boogaard; B R Olsen; M L Warman
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

2.  Clinical and molecular findings in osteoporosis-pseudoglioma syndrome.

Authors:  Minrong Ai; Shauna Heeger; Cynthia F Bartels; Deborah K Schelling
Journal:  Am J Hum Genet       Date:  2005-09-27       Impact factor: 11.025

3.  Homozygosity for frameshift mutations in XYLT2 result in a spondylo-ocular syndrome with bone fragility, cataracts, and hearing defects.

Authors:  Craig F Munns; Somayyeh Fahiminiya; Nabin Poudel; Maria Cristina Munteanu; Jacek Majewski; David O Sillence; Jordan P Metcalf; Andrew Biggin; Francis Glorieux; François Fassier; Frank Rauch; Myron E Hinsdale
Journal:  Am J Hum Genet       Date:  2015-05-28       Impact factor: 11.025

4.  Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG).

Authors:  C M Laine; B D Chung; M Susic; T Prescott; O Semler; T Fiskerstrand; P D'Eufemia; M Castori; M Pekkinen; E Sochett; W G Cole; C Netzer; O Mäkitie
Journal:  Eur J Hum Genet       Date:  2011-03-16       Impact factor: 4.246

5.  Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG).

Authors:  M Celli; P D'Eufemia; P Persiani; A Turchetti; A Febbo; Y D'Alfonso; L Celli; A Zambrano
Journal:  Osteoporos Int       Date:  2017-09-02       Impact factor: 4.507

6.  Osteoporosis-pseudoglioma syndrome: description of 9 new cases and beneficial response to bisphosphonates.

Authors:  Elizabeth A Streeten; Daniel McBride; Eric Puffenberger; Marc E Hoffman; Toni I Pollin; Patrick Donnelly; Paul Sack; Holmes Morton
Journal:  Bone       Date:  2008-05-07       Impact factor: 4.398

7.  Osteoporosis-pseudoglioma syndrome in four new patients: identification of two novel LRP5 variants and insights on patients' management using bisphosphonates therapy.

Authors:  Mohamed S Abdel-Hamid; Rasha M Elhossini; Ghada A Otaify; Sherif F Abdel-Ghafar; Mona S Aglan
Journal:  Osteoporos Int       Date:  2022-02-01       Impact factor: 4.507

Review 8.  The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment.

Authors:  Stefano Stagi; Loredana Cavalli; Salvatore Seminara; Maurizio de Martino; Maria Luisa Brandi
Journal:  Ital J Pediatr       Date:  2014-06-07       Impact factor: 2.638

9.  Osteoporosis-Pseudoglioma in a Mauritanian Child due to a Novel Mutation in LRP5.

Authors:  Noura Biha; S M Ghaber; M M Hacen; Corinne Collet
Journal:  Case Rep Genet       Date:  2016-01-19

Review 10.  Early-Onset Osteoporosis.

Authors:  Outi Mäkitie; M Carola Zillikens
Journal:  Calcif Tissue Int       Date:  2021-07-08       Impact factor: 4.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.